How to Apply


Experimental & Computational Approaches to Cancer Risk Assessment from Chemical [And Drug] Exposure

Monday, November 30, 2015 1:00pm – 5:00pm
650 Albany Street, Boston MA – Room X714/15

1:00 pm Introduction – Stefano Monti, PhD

1-20 – 2:10 pm Chirag Patel, PhD “Studying the Elusive Environment in Large Scale with the Exposome and Environment-Wide Association”

2:15 – 3:05 pm Robert Tanguay, PhD “Exploiting zebrafish as a sensor for chemical bioactivity”

3:10 – 4:00 pm Aravind Subramanian, PhD “The Connectivity Map: Genes, Diseases, and Drugs”

4:00 – 5:00 pm Refreshments and Open Discussion


Symposium: Pathways Leading to Alzheimer Disease

Monday, November 23rd, 2015 12:00pm – 5:00pm
Keefer Auditorium, E-Building, 72 East Concord St, Boston, MA

Keynote Speaker: Peter St George-Hyslop, MD – University of Cambridge
Dennis Selkoe, MD – Harvard Medical School
Joseph El Khoury, MD – Harvard Medical School
Judes Poirier, PhD – McGill University
Karen Duff, PhD – Columbia University


NanoMedicine Symposium – 2015

Nanodelivery Systems for DNA/siRNA/miRNA
Therapies – Cancer and Beyond

April 27, 2015, 1:30pm – 6:00pm
Keefer Auditorium, E-Building, 72 East Concord St, Boston, MA – Boston University School of Medicine

1:30 pm Opening Remarks – Mark Grinstaff, PhD

1-30 – 2:15 pm Leaf Huang, PhD “Remodeling the Tumor Microenvironment to Improve Nanomedicine”

2:15 – 2:30 pm Eudocia Quant Lee, Md, MPH “Challenges for Nanomedicine: Glioblastoma and Brain Metastases”

3:00 – 3:45 pm Jordan J. Green, PhD “Nanomedicines for Cancer and Beyond: From the Inside-Out and the Outside-In”

3:45 – 4:00 pm Coffee Break (In Evans 112A)

4:00 – 4:45 pm Daniel G. Anderson, PhD “Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing”

4:45 – 5:15 pm Panel Discussion“Advancing Nanomedicine – Cancer and Beyond”

5:15 pm Closing Remarks – Katya Ravid, PhD

5:15 – 6:00 pm Reception (In Wilkins Board Room E120)

For full details click here SymposiumAgenda-2015


Parkinson’s Disease Forum

April 10, 2015 8:30am – 2:30pm – Trustees Ballrom, 9th Floor, 1 Silber Way, Boston, MA

Mission: The goal of this event is to foster collaborative research in Parkinson’s disease and related neurodegenerative diseases.

8:30 – 8:45 am Registration

8:45 – 9:00 am Introduction

Ben Wolozin – Pharmacology/Neurology
Marie St. Hilaire – Neurology
Katya Ravid – Evans Center/Medicine

9:00 – 11:00 am Research Updates (15 min each)

9:00 am. – Gloria Walters, PhD – The BU Systems Neuroscience Directive
9:15 am. – Rick Myers, PhD
9:30 am. – Victoria Bolotina, PhD
9:45 am. – Alice Cronin-Golomb, PhD
10:00 am. – Tsuneya Ikezu, MD, PhD

10:15 – 10:30 am Break

10:30 – 11:15 am Research Updates (continued)

10:30 am. – Xue Han, PhD
10:45 am. – Serge Roy PhD
11:00 am. – Lindsay Farrer, Ph.D.

11:15 – 11:45 am APDA Talks (10 min each)

11:15 am. – Sam Frank, M.D.
11:30 am. – Terry Ellis, Ph.D.
11:45 am. – Peter Ash, Ph.D.

11:45 am – 1:45 pm LUNCH

12:45 – 1:45 pm Breakout Sessions

Clinical/ Engineering
Cognition and Parkinson’s disease
Animal Models/Inflammation
Molecular Biology/Therapeutics


Metabolism and Obesity (Mini-Symposium by trainees)

December 18, 2014, 2:00-4:30pm, Room X714, 7th Floor, Evans Biomedical Research Center, 650 Albany Street

2:00 – 2:15 pm Dr. Kalypso Karastergiou (Fried Lab), “Pulsatile cortisol regulates adipose tissue gene expression in vivo and lipid droplet size in vitro”

2:15 – 2:30 pm Kiana Mahdaviani (Shirihai lab), “Mitochondrial dynamics and energy expenditure in BAT”

2:30 – 2:45 pm Ilan Benador (Shirihai lab), “Brown adipocyte respiration”

2:45 – 3:00 pm Nate Miller, “Redox-sensitive GFP Fusion Proteins: A New Tool to look at Redox”

3:00 – 3:20 pm BREAK

3:20 – 3:35 pm Dr. Chris Nogiec, Ph.D. (Simon Kasif and ME Patti), “Metabolic Modeling of Muscle Metabolism Identifies Key Reactions Linked to Insulin Resistance Phenotypes”

3:35 – 3:50 pm Collette Laflamme (Pilch lab), “Adiporedoxin, an upstream modulator of ER oxidative folding and secreted proteins in adipocytes”

3:50 – 4:05 pm Taylor Pickering (Fried lab), “Why are my omental preadipocytes so immature?”

4:05 – 4:20 pm Karel Erion (Corkey lab), “Nutrient Excess and β-Cell Function: Impact on Insulin Content and Secretion”


Etiology and treatment of Type 1 Diabetes

Symposium Chairs: Drs. Hans Dooms, Barbara Corkey and Barbara Nikolajczyk

December 9 2014, L-504, Boston University School of Medicine, 72 East Concord Street

8:30 am Coffee and light breakfast

9:00 – 9:50 am Dr. Matthias von Herrath, Novo Nordisk Type 1 Diabetes R&D Center “New surprises from analyzing the histopathology of human Type 1 Diabetes – implications for treatment design?”

9:50 – 10:15 am Dr. Devin Steenkamp, Boston Medical Center “Type 1 Diabetes: A clinician’s perspective”

10:15 – 10:40 am Dr. Hans Dooms, Bonston University School of Medicine “Targeting the IL-7 pathway in Type 1 Diabetes”

10:40 – 10:55 am BREAK (15 min)

10:55 – 11:45 am Dr. Li Wen, Yale University School of Medicine “Innate immunity and gut microbiome in diabetes”

11:45 – 12:10 am Dr. Doug Lauffenburger, Massachusetts Institute of Technology “In Vivo Systems Analysis of Inflammatory Pathologies”

12:10 – 12:35 pm Dr. Barbara Corkey, Boston University School of Medicine


Immune Cells and Metabolism

Symposium Chairs: Drs. Benjamin Linas, Judith Tsui and Karen Jacobson
Symposium co-chairs: Drs. Barbara Nikolajczyk and Hans Dooms (pre-ARC on TID)

November 21, 2014, Hiebert Lounge, Boston University School of Medicine, 72 E Concord Street

8:45 – 9:35 am. Dr. Jeffrey Rathmell, Duke University “Distinct metabolic programs of CD4 T cell subsets”

10:00 – 10:25 am. Dr. Zhen Jiang, Boston University School of Medicine “Neutrophil activation at early stage of diet-induced obesity”

10:25 – 10:45 am. BREAK (20 min)

10:45 – 11:45 am. Dr. Michael P. Czech, University of Massachusetts School of Medicine “Insulin in control of inflammation and energy expenditure”

11:45 – 12:10 am. Dr. Jongsoon Lee, Harvard Medical School “Adipose tissue macrophage heterogeneity and functions in obesity”

12:10 – 12:30 pm. Dr. Jose J. Fuster Ortuno, Boston University School of Medicine “Non-canonical Wnt signaling: a new player in adipose tissue inflammation”


Hepatitis C Virus (HCV) Pre-ARC Mini-Symposium Transmission, Outcomes, and Healthcare Delivery

(Directors: Drs. Benjamin Linas, Judith Tsui and Karen Jacobson)

June 25, 2014 650 Albany Street, Room X714, 1:00 – 5:00pm

1:00 – 1:15 pm Welcome Drs. Benjamin Linas, Judith Tsui and Karen Jacobson

1:15 – 2:00 pm Arthur Y. Kim, MD Massachusetts General Hospital “Lessons learned from acute HCV”

2:00 – 2:20 pm Manish Sagar, MD Boston University School Medicine “Applying methodologic approaches used in HIV to HCV research”

2:20 – 3:05 pm Todd Allen, PhD Massachusetts General Hospital “Early HCV viral evolution and escape from t-cell responses” Ragon Institute of MGH, MIT and Harvard

3:05 – 3:30 pm BREAK

3:30 – 4:15 pm Shruti H. Mehta, PhD Johns Hopkins Bloomberg School of Public Health “The HCV care continuum: Challenges to successful engagement”

4:15 – 4:35 pm Kevin Cranston, MDiv Massachusetts Department of Public Health “Department of public health responses to the HCV epidemic in MA”

4:35 – 4:55 pm Mari-Lynn Drainoni, PhD Boston University School of Public Health “Screening efforts at BMC”

4:55 – 5:00 pm Thank you and Closing


Arterial Stiffness ARC Mini-Symposium

(Directors: Drs. Richard Cohen, Kathleen Morgan and Francesca Seta)

June 18, 2014 650 Albany Street, Room X715, 10:30am – 1:00pm

10:30 – 10:40 am Welcome

10:40 – 11:00 am Dr. Susanne Vetterkind “Lysine acetylation regulates cytoskeletal remodeling in smooth muscle cells” Research Assistant Professor, Sargeant College, Charles River Campus

11:00 – 11:20 am Tony Gao “Sirtuin1, aging and aortic material stiffness” PhD student, Kathleen Morgan’s Lab, Charles River Campus

11:20 – 11:40 Dr. Jessica Fry “Vascular smooth muscle sirtuin1 in aortic function” Postdoctoral Fellow, Dr. Richard Cohen’s Lab, Medical Campus

12 pm – 1 pm Luncheon Seminar “Vascular Stiffness in Aging and Hypertension” Stephen F. Vatner, MD Director, Cardiovascular Research Institute, Rutgers University, New Jersey Medical School



Co-Hosted by the Evans Center and the Department of Biochemistry (Chairman: Dr. David A. Harris)

May 29, 2014 670 Albany Street, Rooms 107/108, 1 – 5:00 pm

11:30 – 12:00 pm All speakers meeting with all hosting faculty as a group: Drs. Katya Ravid, Deborah Stearns-Kurosawa, Vipul Chitalia

12:00 – 1:00 pm Lunch in W-502 with all members of the Thrombosis Pre-ARC

1:00 – 1:05 pm Welcoming Notes

1:05 – 1:45 pm Dr. Leslie Parise, Professor & Chair of Biochemistry & Biophysics University of North Carolina School of Medicine


1:55– 2:35 pm Dr. Elazer Edelman (, The Thomas D. and Virginia W. Cabot Professor of Health Sciences and Technology at MIT, Professor of Medicine at Harvard Medical School, and Senior Attending Physician in the coronary care unit at the Brigham and Women’s Hospital in Boston.

“THROMBOSIS IN ENDOVASCULAR IMPLANTS: Flow, surfaces and milieu – Virchow knew it first“

2:45 – 3:00 pm Coffee Break

3:00 – 3:30 pm Brief talks by BU faculty

Dr. Deborah Stearns-Kurosawa (10 min) “Modeling Hemolytic Uremic Syndrome”

Dr. Vipul Chitalia (10 min) “Thrombosis in uremic milieu”

Dr. Katya Ravid (10 min) “Lysyl oxidase & thrombosis”

3:40 – 4:20 pm Dr. Bruce Furie, Professor of Medicine Harvard Medical School


4:20 – 5:00 pm Wine & Cheese Reception (DOM and Biochemistry Trainees and faculty are invited)

5:00 – 5:30 pm Individual meetings: Drs. Katya Ravid and Vipul Chitalia meet with Dr. Parise, Dr. Kenneth Walsh meets with Dr. Edelman, Drs. Deborah Stearns-Kurosawa and James Hamilton meet with Dr. Furie

5:45 pm Dinner at Gaslight: Drs. Parise, Edelman and Furie with Drs. David Coleman, Katya Ravid, Deborah Stearns-Kurosawa, Vipul Chitalia, Daniel Remick, David Salant, David Harris and James Hamilton


Etiology and Pathogenesis of Oral Cancer (EPOC) ARC: Head & Neck Cancer Symposium

April 28, 2014, in the Trustees’ Ballroom on the Charles River Campus

”This symposium brought basic scientists and clinicians together to discuss the latest developments in Head & Neck Cancer research and therapy. The goal was to promote interactions between clinicians and researchers from diverse disciplines and to work towards bridging the translational gap.

The keynote addresses was given by Dr. Jatin P Shah, Chief of the Head and Neck Program at Memorial Sloan Kettering Cancer Center, and Dr. Robert A. Weinberg, Founding Member of the Whitehead Institute for Biomedical Research and Professor of Biology at the Massachusetts Institute of Technology. The agenda also included a poster session and four panel discussions on Early Detection and Progenitors, Biomarkers/Genomics, Epidemiology and HPV Disease, and Cancer Treatment and Recurrence.”


Protein Trafficking & Neurodegenerative Disease ARC Symposium: A Focus on Trainees

Hosted by Dr. Lindsay Farrer, ARC Director


Friday, June 14, 2013; 650 Albany Street, X714/715, 2:00 – 4:00pm

2:00 pm Hirohide Asai, M.D., Ph.D. Postdoctoral Fellow, Laboratory of MolecularNeuroTherapeutics (Dr. Tsuneya Ikezu lab), Department of Pharmacology &Experimental Therapeutics “The cellular mechanism of tau protein dissemination in Alzheimer’s Disease”

2:15 pm Maneet Singh, Ph.D. student in Biochemistry (Dr. Konstantin Kandror Lab) “Isolation and proteomics analysis of sortilin-containing vesicles”

2:30 pm Jaeyoon Chung, Ph.D. student in Bioinformatics (Dr. Lindsay Farrer lab)“Genome-wide Association Study for Alzheimer Disease Adjusted for APOEInfluence”

2:45 pm Keynote Presentation: Mark W. Logue, Ph.D, Research Assistant Professor, Department of Biomedical Genetics “Integrating genetics, genomics, and bioinformatics: going small in oursearch for AD mechanisms”

3:15 pm Sarah Sullivan, Ph.D. student in Biology (Dr. Angela Ho lab) “Mint proteins are required for synaptic activity-dependent APP traffickingand Aβ generation”

3:30 pm Tracey Tucker, Ph.D. student in Pharmacology and Experimental,Therapeutics (Dr. Carmela Abraham lab) “Studying Klotho Trafficking through its Polymorphisms”

3:45 pm Katherine Youmans, Ph.D., Postdoctoral Fellow (Dr. Benjamin Wolozinlab), Department of Pharmacology & Experimental Therapeutics“Interactions between RNA binding proteins and tau protein in Alzheimer’s disease”


Mini Symposium: Shining Light on 2013 Evans Center Fellows AwardeesJune17 Evans Fellows 2013

Monday, June 17, 2013; 650 Albany Street, X714/715, 1:30 – 4:00pm

1:30 – 2:00 pm Coffee/Refreshments, Networking and Welcome

2:00 – 2:20 pm Dr. Tamar Aprahamian, Assistant Professor Sex Differences in Adipose Tissue Biology and Related Metabolic Disease ARC “Functional consequences of angiogenesis in adipose tissues”

2:30 – 2:50 pm Dr. Marc Liesa, Postdoctoral AssociateMitochondria in Health and Disease ARC  “A novel antioxidant system constituted by the mitochondrial ATP binding cassette transporter ABCB10”

3:00 – 3:20 pm Dr. GyungahJun, Assistant ProfessorProtein Trafficking & Neurodegenerative Disease ARC “Interdisciplinary Research of Translational Medicine for Alzheimer’s Disease”

3:30 – 3:50 pm Dr. Cesar Sommer, Postdoctoral AssociateBU iPS Bank ARC “Modeling Familial Adenomatous Polyposis using Induced Pluripotent Stem Cells”


ARC Symposium:
Insulin-Sensitive and Resistant Obesity in Bariatric Surgery Patients

AMPK and Sirtuins

Friday, September 20, 2013

650 Albany St., X-715, 8:30am – 12:00pm

8:30 am Walter Pories, MD, Professor, Surgery, Brody School of Medicine, Eastern Carolina University, Greenville, NC, “Impact of Bariatric Surgery

9:20 am Steven Smith, MD Director, Sanford-Burnham Medical Research Institute, Orlando, FL, “Does ‘peripheral’ metabolism determine weight loss success?

10:30 am David Sinclair, PhD Director, Paul Glenn Laboratories for the Biological Mechanisms of Aging, Harvard Medical School, Cambridge, MA, “Sirtuins, obesity and insulin resistance

11:20 am Roundtable Discussion Moderator: Neil Ruderman, MD, DPhilObesity and Insulin Resistance/The CNS and Periphery: Where Does it Begin?

12:00 pm Luncheon and Networking (X-714)

Sponsored by: Drs. Neil Ruderman, Caroline Apovian and Kostya Kandror, Directors Metabolic Disease and Adipose Tissue: Studies in Patients Undergoing Bariatric Surgery ARC


Evans Center Affinity Research Collaborative (ARC*) mini-symposium on

Wednesday, October 30, 2013, 1:00 – 4:00pm

650 Albany Street – X714/15

1:00-1:15 pm Introduction, Stefano Monti, Ph.D & David Sherr, Ph.D. – ARC co-directors
1:15-2:15 pm  Trainees’ Highlights & Collaborations:”Genomic Models of Chemical Carcinogenicity“, Daniel Gusenleitner; “A high-throughput genomics approach to understanding airway exposure and lung disease“, Elizabeth Moses; “AhR-mediated Exposures in Breast Cancer“, Elisabeth Stanford

2:20-3:00 pmHigh-dimensional Experiments and High-resolution readouts in Hepatotoxicity“, David Thomas, Ph.D., Cancer Program, Broad Institute of MIT & Harvard

3:05-3:45 pmObservational Epidemiology and Chemical Carcinogenicity“, Susan Jick, DSc, BU SPH



Brain control and cardiovascular disease in obesity

Co-sponsored by Evans Center for Interdisciplinary Biomedical Research (ECIBR) Affinity Research Collaborative (ARC) “SEX DIFFERENCES IN ADIPOSE TISSUE BIOLOGY AND RELATED METABOLIC DISEASE” and the Adipose Biology and Nutrient Metabolism and Transgenic Cores of the Boston Nutrition Obesity Research Center (BNORC)

Friday, November 22, 2013, Boston University Medical Campus, Evans Biomedical Research Center, 650 Albany Street, 7th Floor, Rooms 714 & 715, 1:30 – 4:30pm

1:30 – 2:15 pm

Pathophysiology of obesity hypertension: role of leptin and CNS melanocortin system

John E. Hall, PhD, Arthur C. Guyton Professor and Chair,Director, Mississippi Center for Obesity Research

2:15 – 3:00 pm

Obesity-Induced Hypertension:  New Insights From The Emerging Biology of Obesity

Allyn L. Mark, MD, Roy J. Carver Chair in Internal Medicine Founding Co-Director, University of Iowa Obesity Research Education Initiative Professor of Internal Medicine, Cardiovascular Medicine


3:30 – 4:15 pm

The role of brain insulin in controlling cardiovascular risk factors

Christoph Buettner, PhD, Associate Professor, Mount Sinai Hospital



December 10, 2013, Boston University Photonics Building, Rm 906, 1:15-5:15pm, Reception 5:15-6:00pm

Hosted by Boston University Nanotheranostics ARC (Affinity Research Collaborative)


Ashutosh Chilkoti, PhD  Theo Pilkington Professor of Biomedical Engineering, Director of Graduate Studies, Center for Biologically Inspired Materials and Materials Systems, Biomedical Engineering, Pratt School of Engineering, Duke University

Paula T. Hammond, PhD, David H. Koch Professor in Engineering, Department of Chemical Engineering, Massachusetts Institute of Technology

Piotr Grodzinski, PhD, Director, NCI Office of Cancer Nanotechnology Research, National Institutes of Health


Evans Center pre-Affinity Research Collaborative (ARC*) mini-symposium on:

Computational Genomic Models of Environmental & Chemical Carcinogenicity

Thursday, October 25, 2012, 650 Albany Street – X714/15, 3:30-6:00pm

3:30-3:45 pm Introduction:  Stefano Monti, Ph.D & David Sherr, Ph.D. – co-chairs

3:50-4:20 pm An Overview of Drug Matrix and its Application to Cancer Hazard Characterization

Scott Auerbach, Ph.D., National Toxicology Program / NIEHS

4:30-5:00 pm High-Throughput Transcriptomics – The Connectivity Map v2.0

Aravind Subramanian, Ph.D., Cancer Program, Broad Institute of MIT & Harvard

5:00-5:30 pm Open Discussion

5:30-6:00 pm Cheer/Cheese reception


Evans Center Nanotheranostics ARC

Co-Sponsored by the Boston University Center for Nanoscience and Nanobiotechnology

Nanotechnology – Therapeutics – Diagnostics

November 20, 2012, Photonics, 8 St. Mary’s St, Roo 906, 1:30-6:30pm

1:30 pm Opening Remarks by Evans Center Director Katya Ravid, DSc/PhD, Professor of Medicine and Biochemistry
1:35 pm Nanodiagnostics for Cell Engineering Invited guest, Jeff W.M. Bulte, PhD, Professor of Biomedical Engineering, Chemical Engineering, and Radiology, Director, Institute of Cell Engineering, Johns Hopkins School of Medicine, Baltimore, MD
2:35 pm Multifunctional Nanoparticles for Medical Applications – from discovery to clinical trials Invited guest, Omid C. Farokhjad, MD, Associate Professor of Anesthesia, Harvard Medical School, Boston MA, Director, Laboratory of Nanomedicine and Biomaterials, Brigham and Women’s Hospital, MA
3:35 pm Coffee Break
3:50 pm Nanotheranostics for Cardiovascular Disease and Cancer Invited guest, Gregory M. Lanza, MD, PhD, FACC, Washington University Consortium for Translational Research in Advancing Imaging and Nanomedicine, St. Louis, MO
4:50 pm Advancing NanoMedicine through NanoTheranostics – Opportunities, Challenges and Priorities Panel Discussion
Panelists: Greg M. Lanza; Jeff W. M. Bulte; Katya Ravid; Bennett Goldberg, PhD, Professor and Director of BU Center for Nanoscience and Nanobiotechnology; David Center, MD, Professor and Director of BU Clinical and Translational Science Institute; Alex Norbash, MD, FACR, Professor and Chair, Radiology; Jennifer E. Rosen, MD, FACS, Assistant Professor, Surgery
5:25 pm Closing Remarks by Dr. Bennett Goldberg
5:30 pm Reception



October 25, 2011, 1-5:30p

Thank you for making this event such a success!! Slides will be posted related to this symposium.

The Obesity, Cancer and Inflammation ARC, co-directed by Drs Gerald Denis and Barbara Nikolajczyk, hosted this exciting symposium focused on the cellular, molecular and epidemiological connections between obesity and cancer, some of which are likely based on inflammatory factors.

As part of an exciting afternoon of speakers, a greatly anticipated visit by Drs Christopher Still and Glenn Gerhard, from Geisinger Medical Center, emphasized their superbly well-characterized bariatric cohort and the metabolic improvements they observe after surgery. They joined in a lively debate on “Drugs vs Surgery for Obesity”, led by Dr Caroline Apovian, Director, Nutrition and Weight Management Center, BMC. Dr Deborah Bowen of the BU School of Public Health, and an expert in breast cancer, who discussed connections between socioeconomic variables and obesity. Dr Lynn Moore from BUSM Preventive Medicine discussed cancer rates and obesity in Framingham Study subjects. Dr Jennifer Snyder-Cappione, an immunologist formerly of UCSF discussed the roles of inflammatory cells in adipose tissue. Dr Valentina Perissi, a new member of the faculty in the Department of Biochemistry, delivered a presentation on novel pathways that link inflammation and insulin resistance in obesity. Dr Nikolajczyk presented new data on inflammatory cell cross talk in Type 2 diabetic patients. Dr Nikolajczyk also acted as a Discussant to summarize the day’s provocative themes and brought the event to a close.

This event was held at 650 Albany Street, EBRC conference room 714.


“New Frontiers in Molecular Medicine”
Mini-Symposium Honoring Dr. John ‘Jack’ Murphy

Friday, October 1, 2010
EBRC(X Bldg) 714&715, 650 Albany Street

October 1, 2010

Welcome and Greetings: Dr. Katya Ravid, Director, Evans Center

Plaque Presentation: Dr. David Coleman, Chairman, Department of Medicine

Introductory Remarks: Dr. Jack Murphy, Section Chief, Molecular Medicine

Dr. William Bishai, from Johns Hopkins School of Medicine: ”Intoxicated by Tuberculosis

Dr. Fadi G. Lakkis, from Thomas E. Starzl Transplantation Institute, Pittsburgh, PA: ”The Innate Immune Response to Transplanted Organs

Dr. Francine Foss, from Yale University: ”The Evolution of ONTAK: From Lymphoma to Immunotherapy

Dr. John Mekalanos, from Harvard Medical School: “Bacteriophage and phage-like structures in the evolution of pathogenic Vibrio cholerae

Dr. David Relman, from Stanford University: “The Human Body as Microbial Ecosystem

Dr. Rino Rappuloi, from Novartis Vaccines and Diagnostics: ”CRM197 and the Beginning of Modern Vaccines

Speakers joined Graduate Students and Post-Doctoral Fellows for a luncheon and lively discussion, and conversed with attendees during a special Oktoberfest reception to close our celebration.


“Controlling Hypertension: from basic research to the clinic”

April 16, 2010 (building X714-715)

Dr. Coleman presents a Recognition Plaque to Dr. H. Gavras coleman.gavras.1

Introduction by Dr. Haralambos Gavras

1. John Hall, PhD
Professor and Chairman
Department of Physiology
University of Mississippi Medical Center
Jackson, MS
Title: “Pathophysiology of hypertension in obesity/metabolic syndrome”

2. Genevieve Nguyen, M.D., Ph.D., FAHA
Senior Scientist
Collège de France
Paris, France
Title: “The (pro)renin receptor: biology and functions”

3. Hans Brunner, M.D.gavrasProfessor of Medicine
Division of Hypertension and Vascular Medicine
Centre Hospitalier, Universitaire Vaudois (CHUV)
Title:  “The development of renin inhibitors”

4. David Hyman, MD
Professor & Chief of General Internal Medicine
Baylor College of Medicine
Houston, TX
Title:  “How come BP is not controlled yet? Inert MDs? 
Inert patients? Inert systems? Inert drugs?  Incorrect goals. ”



co-organized by BU Nanotechnology Center, Evans Center and DOM (chaired by: Drs. Bennett Goldberg and Selim Unlu) Wednesday, May 13, 2009

Dr. Jeffery Schloss, co-chair of the NIH Nanotechnology Task Force “$1000 genomes — who needs them and how will we get them?”

Dr. Shuvo Roy, University of California, San Francisco -”Towards Total Renal Replacement using Silicon Nanopore Membrane Technology”

Dr. Daniel Kohane, Harvard Medical School and Children’s Hospital, Boston – “Drug delivery systems: nano, micro, and macro?”

IN PREPARATION for the symposium, faculty in nanoscience from Boston University presented research seminars in each of three areas


Mini-symposium on Stem Cells and Regenerative Medicine

(chaired by Dr. Katya Ravid), April 17, 2009

The Program:

1. “Development of induced pluripotent stem cells (iPS)”
Konrad Hochedlinger, Ph.D.
Associate Professor of Medicine
Harvard Medical School
Cancer Center and Center for Regenerative Medicine

2. “Stem cells of the skin: their biology and clinical promise”
Elaine Fuchs, Ph.D.
Rebecca C. Lancefield Professor
Investigator, Howard Hughes Medical Institute
Laboratory of Mammalian Cell Biology and Development
The Rockefeller University

3. “Endothelial progenitor cells in regenerative medicine “
Douglas W. Losordo, M.D.
Eileen M. Foell Professor of Heart Research
Director, Program in Cardiovascular Regenerative Medicine
Director, Feinberg Cardiovascular Research Institute
Northwestern University Feinberg School of Medicine

4. “Stem cell self-renewal versus cancer cell proliferation”
Sean J. Morrison, PhD
Henry Sewall Professor in Medicine
Director, Center for Stem Cell Biology
Howard Hughes Medical Institute Investigator